SNDX Institutional Ownership & Shareholders

SYNDAX PHARMACEUTICALS INC (SNDX) is currently held by 234 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $2.31B based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.

Blackrock, Inc. is currently the largest disclosed institutional shareholder of SNDX tracked by InsiderSet, reporting ownership valued at approximately $197.18M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $123.12M, representing an estimated loss of -37.56% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 46% of the total disclosed SNDX value among the investors covered in this analysis. Major shareholders include Blackrock, Inc., Kynam Capital Management, Lp, Goldman Sachs Group Inc, and several other long-term asset managers with concentrated positions in SYNDAX PHARMACEUTICALS INC (SNDX).

This page ranks the largest institutional SNDX shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

234

Total Reported Value

$2.31B

Largest Holder

Blackrock, Inc.

Largest Position

$197.18M

Insider Transactions (90d)

1

Latest Filing Quarter

Q2 2026

New Institutional Positions

52

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Blackrock, Inc.0.00%9,020,006$197,177,353$123,123,082-$74,054,271-37.56%
Kynam Capital Management, Lp9.73%8,050,959$175,993,964$109,895,590-$66,098,374-37.56%
Goldman Sachs Group Inc0.01%5,861,265$128,127,253$80,006,267-$48,120,986-37.56%
State Street Corp0.00%5,658,424$123,693,149$77,237,488-$46,455,661-37.56%
Bank Of America Corp0.01%4,045,094$88,425,755$55,215,533-$33,210,222-37.56%
Vanguard Capital Management Llc0.00%3,927,892$85,863,719$53,615,726-$32,247,993-37.56%
Deerfield Management Company, L.P.0.86%3,779,900$82,628,614$51,595,635-$31,032,979-37.56%
Eversept Partners, Lp3.33%2,798,210$61,168,871$38,195,567-$22,973,305-37.56%
Geode Capital Management, Llc0.00%2,584,136$56,499,563$35,273,456-$21,226,107-37.57%
Hood River Capital Management Llc0.41%2,564,279$56,055,139$35,002,408-$21,052,731-37.56%
Kingdon Capital Management, L.L.C.7.37%2,500,000$54,650,000$34,125,000-$20,525,000-37.56%
Millennium Management Llc0.03%2,053,960$44,899,566$28,036,554-$16,863,012-37.56%
Vanguard Portfolio Management Llc0.00%1,921,796$42,010,461$26,232,515-$15,777,946-37.56%
Ubs Group Ag0.01%1,893,750$41,397,375$25,849,688-$15,547,688-37.56%
Elmind Capital, Lp10.19%1,855,000$40,550,300$25,320,750-$15,229,550-37.56%
Bnp Paribas Asset Management Holding S.A.0.04%1,790,173$39,133,182$24,435,861-$14,697,321-37.56%
Candriam S.C.A.0.17%1,696,040$37,039,763$23,150,946-$13,888,817-37.50%
Soleus Capital Management, L.P.1.23%1,628,039$35,588,933$22,222,732-$13,366,201-37.56%
Two Sigma Investments, Lp0.03%1,578,125$34,497,812$21,541,406-$12,956,406-37.56%
Orbimed Advisors Llc0.64%1,542,000$33,708,120$21,048,300-$12,659,820-37.56%
Nuveen, Llc0.01%1,364,575$29,829,610$18,626,449-$11,203,161-37.56%
Mpm Bioimpact Llc1.78%1,333,523$29,150,813$18,202,589-$10,948,224-37.56%
Aisling Capital Management Lp6.10%1,316,806$28,785,379$17,974,402-$10,810,977-37.56%
Woodline Partners Lp0.08%1,250,760$27,341,614$17,072,874-$10,268,740-37.56%
D. E. Shaw & Co., Inc.0.02%1,239,954$27,105,395$16,925,372-$10,180,023-37.56%
Silverarc Capital Management, Llc2.95%1,214,390$26,546,565$16,576,424-$9,970,142-37.56%
Prosight Management, Lp4.52%1,200,000$26,232,000$16,380,000-$9,852,000-37.56%
Catalio Capital Management, Lp4.44%1,196,807$25,144,915$16,336,416-$8,808,499-35.03%
Trails Edge Capital Partners, Lp3.85%1,110,000$24,264,600$15,151,500-$9,113,100-37.56%
Ensign Peak Advisors, Inc0.04%990,969$23,149,036$13,526,727-$9,622,309-41.57%
Algert Global Llc0.27%1,051,465$22,985,025$14,352,497-$8,632,528-37.56%
Bank Of New York Mellon Corp0.00%1,040,079$22,736,118$14,197,078-$8,539,040-37.56%
Sphera Funds Management Ltd.3.17%1,014,606$22,179,287$13,849,372-$8,329,915-37.56%
Loomis Sayles & Co L P0.03%923,624$20,190,420$12,607,468-$7,582,952-37.56%
Parkman Healthcare Partners Llc1.97%877,256$19,176,816$11,974,544-$7,202,272-37.56%
Palo Alto Investors Lp2.61%864,986$18,908,594$11,807,059-$7,101,535-37.56%
Aqr Capital Management Llc0.01%853,304$18,653,226$11,647,600-$7,005,626-37.56%
Northern Trust Corp0.00%845,537$18,483,439$11,541,580-$6,941,859-37.56%
Charles Schwab Investment Management Inc0.00%814,303$17,800,664$11,115,236-$6,685,428-37.56%
Vanguard Fiduciary Trust Co0.00%633,509$13,848,507$8,647,398-$5,201,109-37.56%
Morgan Stanley0.00%588,979$12,875,080$8,039,563-$4,835,517-37.56%
Rhenman & Partners Asset Management Ab1.16%560,250$12,247,065$7,647,413-$4,599,653-37.56%
Apis Capital Advisors, Llc1.18%556,000$12,154,160$7,589,400-$4,564,760-37.56%
Panagora Asset Management Inc0.04%546,517$11,946,862$7,459,957-$4,486,905-37.56%
Qube Research & Technologies Ltd0.01%477,182$10,431,199$6,513,534-$3,917,665-37.56%
First Trust Advisors Lp0.01%456,700$9,983,462$6,233,955-$3,749,507-37.56%
Susquehanna International Group, Llp0.01%454,101$9,926,648$6,198,479-$3,728,169-37.56%
Granahan Investment Management, Llc0.35%446,988$9,771,158$6,101,386-$3,669,772-37.56%
Knott David M Jr5.05%437,245$9,558,176$5,968,394-$3,589,782-37.56%
Jump Financial, Llc0.08%402,846$8,806,214$5,498,848-$3,307,366-37.56%
Showing 50 of 232

Frequently asked questions about SNDX

  • Who are the largest institutional holders of SNDX?

    The largest institutional holders of SNDX reported in the latest SEC Form 13F filings include Blackrock, Inc., Kynam Capital Management, Lp, Goldman Sachs Group Inc, State Street Corp, and Bank Of America Corp. InsiderSet ranks institutional holders by their latest reported SNDX position.

  • What is SNDX institutional ownership?

    This page tracks SNDX positions reported by institutional investment managers through SEC Form 13F. SYNDAX PHARMACEUTICALS INC (SNDX) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.

  • How many institutions own SNDX?

    InsiderSet currently tracks 234 institutional managers reporting SNDX holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of SNDX shareholders.

  • How much SNDX stock do institutions own?

    Institutional investment managers disclosed approximately $2.31B in SNDX holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.

  • When was SNDX institutional ownership last updated?

    The latest SNDX institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.

  • Are institutional SNDX holdings real-time?

    No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its SNDX position after the reporting date.

  • Are institutions buying or selling SNDX?

    Institutional buying and selling can be analyzed by comparing SNDX positions across consecutive 13F reporting periods. InsiderSet's SNDX Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View SNDX ownership changes.

  • How has SNDX institutional ownership changed over time?

    InsiderSet tracks SNDX institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.